Domov › Metastatická rakovina › Kalifornia

Klinické štúdie Metastatická rakovina v štáte Kalifornia

130 štúdií pre Metastatická rakovina hľadá účastníkov v zariadeniach v štáte Kalifornia.

Mestá v štáte Kalifornia

Oficiálny text štúdie (anglicky)

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Avenzo Therapeutics Recruiting Site, San Francisco

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07193511

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

City of Hope, Duarte
University of California San Diego, San Diego

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07562152

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

PCR Oncology, Arroyo Grande
Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
a 15 ďalších

Prebieha náborFáza 2

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
a 2 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

University of California San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Medical Center, Los Angeles

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06234605

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

University of California - Los Angeles, Los Angeles

Prebieha náborFáza 1

Vek 19 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06586957

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

City of Hope Comprehensive Cancer Center, Duarte
University of California Los Angeles, Los Angeles
University of California San Diego Moores Cancer Center, San Diego

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06625775

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

University of California Irvine, Orange
Stanford, Palo Alto
University of California San Francisco, San Francisco

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05287945

A Study of ASP3082 in Adults With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
UCLA Santa Monica Hematology Oncology, Santa Monica

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT05382559

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 9, La Jolla
ALX Center 11, Santa Monica

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07085091

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Cedars-Sinai Medical Center, Beverly Hills
Norris Comprehensive Cancer Center, Los Angeles
Stanford Cancer Center, Palo Alto
a 2 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06943755

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

UCSF at Berkeley Outpatient Center, Berkeley
Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
UCSD Medical Center - Encinitas, Encinitas
a 21 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Duarte, Duarte
Providence Medical Foundation, Santa Rosa

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07277413

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Fountain Valley
Research Site, Glendale
Research Site, Sacramento

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

City of Hope, Duarte
UC San Diego Moores Cancer Center, La Jolla
UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07007559

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Children's Hospital Los Angeles, Los Angeles
University of California at Los Angeles, Los Angeles

Prebieha náborFáza 1/2

Do veku 25 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT04094610

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

UC San Diego Medical Center - Encinitas, Encinitas
Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UCI Health - Irvine, Irvine
a 14 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06989437

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Oncura Health - Anaheim, Anaheim
Memorial Care Orange Coast Medical Center Attn, Fountain Valley
MemorialCare Orange Coast Medical Center, Fountain Valley
a 20 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07222566

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, Santa Monica

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07229313

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

UCI Medical Center, Orange
Stanford Medicine, Palo Alto
UC Davis Comprehensive Cancer Center, Sacramento

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT05118789

Intratumoral N17350 in Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles
UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
Scripps Clinic Torrey Pines - La Jolla, San Diego
a 1 ďalších

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07339176

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

USC Norris Comprehensive Cancer Center, Los Angeles
UCSF Medical Center at Mount Zion, San Francisco
Stanford Cancer Institute, Stanford

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06915753

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Pacific Cancer Care, Monterey
Torrance Memorial Physician Network-Cancer Care, Torrance
John Muir Health, Walnut Creek

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07028489

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07114601

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
City of Hope, Duarte, Duarte
City of Hope Lennar, Irvine
a 6 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213804

SLV-154 Treatment of Advanced Cancers

Hoag Memorial Hospital Presbyterian, Newport Beach

Prebieha náborFáza 1

Vek 12 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06771219

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
TRIO-US (Translational Research in Oncology-US), Los Angeles
UCLA Hematology/Oncology - Santa Monica, Los Angeles
a 4 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Community Cancer Institute, Clovis
City of Hope, Duarte
Epic Care - Emeryville, Emeryville
a 19 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

California Research Institute (CRI), Los Angeles

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07262619

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06128551

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Hoag Memorial Hospital Presbyterian, Newport Beach

Prebieha náborFáza 1

Vek 18 až 99 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07403721

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
City of Hope Investigational Drug Services (IDS), Duarte
UC San Diego Medical Center - Encinitas, Encinitas
a 13 ďalších

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07227415